Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. Sanofi–GSK COVID-19 vaccine - Wikipedia

   en.wikipedia.org/wiki/Sanofi–GSK_COVID-19_vaccine

   The Sanofi–GSK COVID‑19 vaccine is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike protein, which is produced in insect cells via a baculovirus vector. It also includes an adjuvant made by GSK. It uses the same technology as Sanofi's Flublok influenza vaccine. [8][9]

3. GSK's RSV, Shingles vaccines show on-par immune ... - AOL

   www.aol.com/news/gsks-rsv-shingles-vaccines-show...

   The trial testing the immune response of co-administration of GSK's blockbuster vaccines, Shingrix and Arexvy, in adults over 50 years of age, met the main goal of the study. The co-administration ...

4. List of COVID-19 vaccine authorizations - Wikipedia

   en.wikipedia.org/wiki/List_of_COVID-19_vaccine...

   The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria[6]and Covishield,[7]is a viral vector vaccine[8]produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. [8][9][10]Finland, Denmark, and Norway suspended the use of the Oxford ...

5. GSK plc - Wikipedia

   en.wikipedia.org/wiki/GSK_plc

   GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.

6. US FDA expands GSK's RSV vaccine approval to adults ... - AOL

   www.aol.com/news/us-fda-expands-gsks-rsv...

   (Reuters) -The U.S. Food and Drug Administration approved the expanded use of GSK's respiratory syncytial virus (RSV) vaccine on Friday in adults aged between 50 and 59, making it the first shot ...

7. GSK CEO says RSV vaccine revenue to top 1 billion pounds in ...

   www.aol.com/news/gsk-ceo-says-rsv-vaccine...

   NEW YORK/LONDON (Reuters) -GSK CEO Emma Walmsley gave an upbeat assessment of the British drugmaker's new respiratory syncytial virus (RSV) vaccine on Thursday and said the costs of Zantac ...

8. List of GSK plc products - Wikipedia

   en.wikipedia.org/wiki/List_of_GSK_plc_products

   Fendrix (hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)) Fluarix (trivalent) & Fluarix (quadrivalent) (seasonal influenza vaccine (3 strain and 4 strain)) FluLaval (trivalent) & FluLaval (quadrivalent) (seasonal influenza vaccine (3 strain and 4 strain)) Havrix (for hepatitis A vaccine, inactivated) Hepatyrix (for hepatitis A (inactivated ...

9. GSK Sees Strong Demand For Vaccines and Asthma Drugs ... - AOL

   www.aol.com/finance/gsk-sees-strong-demand...

   Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% excluding COVID. Vaccines’ sales increased 16% at constant currency ...